Free Trial

Perrigo Company plc (NYSE:PRGO) Receives Average Rating of "Hold" from Analysts

Perrigo logo with Medical background

Perrigo Company plc (NYSE:PRGO - Get Free Report) has been assigned a consensus recommendation of "Hold" from the five research firms that are covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $35.00.

A number of brokerages recently issued reports on PRGO. Jefferies Financial Group reissued a "hold" rating and set a $30.00 price target (down previously from $50.00) on shares of Perrigo in a research report on Monday, September 23rd. Argus cut Perrigo from a "buy" rating to a "hold" rating in a research report on Tuesday. Canaccord Genuity Group reiterated a "buy" rating and set a $42.00 price objective on shares of Perrigo in a research note on Monday, September 30th. StockNews.com cut shares of Perrigo from a "buy" rating to a "hold" rating in a research report on Saturday. Finally, Piper Sandler cut shares of Perrigo from an "overweight" rating to a "neutral" rating and decreased their price objective for the company from $34.00 to $27.00 in a research note on Monday, January 6th.

Read Our Latest Stock Analysis on Perrigo

Perrigo Stock Performance

PRGO traded down $0.77 during trading on Tuesday, hitting $23.57. The stock had a trading volume of 1,794,229 shares, compared to its average volume of 1,585,241. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. The firm has a market cap of $3.22 billion, a price-to-earnings ratio of -20.15 and a beta of 0.53. The company has a 50 day moving average price of $26.71 and a 200-day moving average price of $26.80. Perrigo has a one year low of $23.14 and a one year high of $33.96.

Perrigo (NYSE:PRGO - Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.81 EPS for the quarter, hitting analysts' consensus estimates of $0.81. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The business had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.12 billion. During the same period last year, the firm earned $0.64 earnings per share. Perrigo's revenue for the quarter was down 3.2% compared to the same quarter last year. As a group, research analysts predict that Perrigo will post 2.56 EPS for the current year.

Perrigo Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Friday, November 29th were issued a dividend of $0.276 per share. The ex-dividend date was Friday, November 29th. This represents a $1.10 annualized dividend and a dividend yield of 4.68%. Perrigo's dividend payout ratio (DPR) is presently -94.02%.

Insider Activity at Perrigo

In other news, Director Jeffrey B. Kindler sold 17,598 shares of the firm's stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $28.27, for a total transaction of $497,495.46. Following the completion of the transaction, the director now directly owns 5,409 shares in the company, valued at $152,912.43. This trade represents a 76.49 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Perrigo

Large investors have recently modified their holdings of the company. Versant Capital Management Inc acquired a new position in shares of Perrigo during the fourth quarter valued at about $45,000. GAMMA Investing LLC boosted its holdings in Perrigo by 93.7% in the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company's stock worth $49,000 after acquiring an additional 929 shares in the last quarter. Central Pacific Bank Trust Division increased its holdings in shares of Perrigo by 33.3% during the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company's stock valued at $51,000 after acquiring an additional 500 shares in the last quarter. Venturi Wealth Management LLC acquired a new position in Perrigo during the third quarter worth $56,000. Finally, KBC Group NV boosted its stake in Perrigo by 25.1% during the 3rd quarter. KBC Group NV now owns 4,517 shares of the company's stock valued at $118,000 after purchasing an additional 905 shares during the last quarter. 95.91% of the stock is currently owned by institutional investors and hedge funds.

About Perrigo

(Get Free Report

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Featured Stories

Analyst Recommendations for Perrigo (NYSE:PRGO)

Should You Invest $1,000 in Perrigo Right Now?

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Analysts boosting their targets. Find out how Oracle’s cloud push is reshaping its business and driving new growth opportunities.

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines